U.S. federal trademark · Serial No. 77807446 · Reg. No. 3819897
Medical testing services that utilize a patient's clinical, molecular and morphometric information for predicting the probability of clinical failure post-prostatectomy or biopsy in the absence of other treatment and predicting a patient's progression of disease and providing information useful to a doctor in prescribing a recommended therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.